CD4 and COVID-19: Nevertheless, our results are consistent with the hypothesis that the early presence of high numbers of functional α-CCCs/SARS-CoV-2 cross-reactive CD4+ and CD8+ T cells targeting multiple antigens was associated with protection from symptomatic and fatal SARS-CoV-2 infections in unvaccinated COVID-19 patients (99).